Haruhiko Takeda

10PUBLICATIONS
25CO-AUTHORS
Medical virologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 29, 2026
MSH2 prevents liver tumorigenesis by regulating cell cycle checkpoints under chronic inflammation.

Shigeharu Nakano, Atsushi Takai, Eriko Iguchi

|Sep 13, 2025
Lenvatinib Versus Atezolizumab Plus Bevacizumab as First-Line Treatment for Advanced Hepatocellular Carcinoma With a CRAFITY Score of 2: A Multi-Center Retrospective Study.

Masayuki Ueno, Haruhiko Takeda, Atsushi Takai

|Sep 27, 2024
TERT upregulation promotes cell proliferation via degradation of p21 and increases carcinogenic potential.

Masako Mishima, Atsushi Takai, Haruhiko Takeda

|Feb 16, 2024
Integrated analyses of the genetic and clinicopathological features of cholangiolocarcinoma: cholangiolocarcinoma may be characterized by mismatch-repair deficiency.

Kenta Makino, Takamichi Ishii, Haruhiko Takeda

|Jun 22, 2023
ELF3 suppresses gallbladder cancer development through downregulation of the EREG/EGFR/mTOR complex 1 signalling pathway.

Takeharu Nakamura, Yoshihiro Nishikawa, Masahiro Shiokawa

|Feb 27, 2023
Evolutional transition of HBV genome during the persistent infection determined by single-molecule real-time sequencing.

Soichi Arasawa, Haruhiko Takeda, Atsushi Takai

Pageof 2

Frequent Collaborators

4 joint publications

Yuji Eso

3 joint publications

Etsuro Hatano

2 joint publications

Takahiro Shimizu

2 joint publications

Masako Mishima